NMN Benefits & Anti-Ageing Evidence: What Studies Show

See the ageing-related effects reported in animal and human NMN studies, separated clearly from what remains unproven for people and finished products.

By Yaoxing, Founder of GOPRYME · 7 September 2026 · Updated 8 September 2026

Human NMN studies most consistently show that oral NMN can affect blood NAD-related measures over the short term. Evidence for broader benefits—such as metabolism, physical performance, sleep, energy, or healthy ageing—is mixed, outcome-specific, and not proof that every finished product will work. NMN should not be marketed as reversing ageing or guaranteeing a result.

What benefits are people searching for?

NMN is commonly discussed alongside energy, metabolism, exercise, sleep, and longevity. These are different outcomes. A study measuring blood NAD+ cannot by itself prove improved energy, and a result in one population cannot automatically be applied to healthy adults of every age.

Human NMN evidence at a glance

Question	What current human evidence suggests	Important limit
Can NMN affect blood NAD measures?	Several short-term trials and a 2025 meta-analysis reported increases in blood NAD-related measures.	A biomarker change is not the same as a felt or clinical benefit.
Does NMN improve glucose or lipid outcomes?	Two recent reviews found no significant overall benefit across most assessed glucose and lipid outcomes.	Trials were relatively few, short, and mainly involved middle-aged or older adults.
Does NMN improve physical performance?	Individual studies have reported signals for selected measures, while a 2024 review found non-significant pooled improvement in physical-performance parameters.	Measures, populations, doses, and study designs differed.
Does NMN improve sleep or fatigue?	One 12-week study in older Japanese adults reported time- and outcome-specific findings.	That result is not a universal sleep claim and does not prove the same effect for a retail product.
Why is NMN studied in ageing?	Animal research has reported effects on several age-associated physiological measures, while short human trials have reported NAD+ changes and selected functional or metabolic signals.	Animal effects and short-term human signals do not prove reversed human ageing or longer life.
Is long-term use proven safe?	Short-term trials have generally reported favourable tolerability.	Long-term safety, rare effects, and individual suitability remain uncertain.

Why blood NAD+ is not the same as “more energy”

NAD+ participates in cellular reactions, and NMN is related to its biosynthesis. That explains the research interest. It does not mean that increasing a measured blood marker produces an immediate stimulant effect or a guaranteed improvement in fatigue, mood, work performance, or exercise.

NMN is not caffeine. If persistent tiredness is the concern, a supplement page cannot identify the cause or replace qualified assessment.

What did the 2025 meta-analysis find?

The 2025 review included 12 studies and 513 participants. It found an overall increase in blood NAD levels, while most clinically relevant outcomes examined were not significantly different from control. The authors also reported risk-of-bias concerns and warned that benefits may be exaggerated in the field.

A separate review of eight randomized trials, covering 342 mainly middle-aged or older adults, found no significant overall improvement in fasting glucose, fasting insulin, HbA1c, insulin-resistance measures, or lipid profile.

What ageing-related effects have studies reported?

There is evidence relevant to ageing research, but it sits on different rungs of the evidence ladder:

Study	Reported effect	How to interpret it
12-month mouse study	NMN reduced several age-associated physiological declines in mice, including changes in energy metabolism, physical activity, insulin sensitivity, eye function, and age-associated gene expression.	This is important preclinical evidence. It cannot establish an anti-ageing effect in humans.
80 healthy middle-aged adults, 60 days	Daily 300, 600, or 900 mg increased blood NAD concentrations. Walking-distance changes were greater than placebo. A calculated blood biological-age score stayed unchanged in treated groups while increasing in placebo.	The trial was short, used per-protocol analysis, relied on an algorithmic biological-age measure, and disclosed commercial affiliations. It did not demonstrate age reversal or lifespan extension.
25 postmenopausal women with prediabetes, 250 mg daily for 10 weeks	NMN increased insulin-stimulated muscle glucose disposal and muscle insulin-signalling measures compared with placebo.	This is a specific metabolic result in a narrowly defined population, not a universal anti-ageing outcome.
Systematic reviews of human trials	Blood NAD-related measures rise more consistently than broader clinical outcomes; pooled metabolic and physical-performance results are mostly non-significant or uncertain.	The total human evidence remains limited by short duration, small samples, heterogeneous methods, and risk of bias.

The correct conclusion is not that “nothing has been shown.” Studies have reported effects. The correct conclusion is that the reported effects must be named precisely and cannot be converted into a promise that a retail NMN supplement reverses ageing.

What about physical performance and sleep?

A 2024 systematic review included ten studies and 437 participants. Its pooled physical-performance changes were not statistically significant. One 12-week randomized study in 108 older Japanese adults reported selected improvements related to lower-limb function and drowsiness, with results differing by timing and outcome.

Those findings can be described as research signals, not as a promise that NMN improves sleep, prevents fatigue, or boosts performance for every customer.

Can evidence from an ingredient prove a finished product?

No. Ingredient research and finished-product evidence are separate layers. To transfer a finding responsibly, ask whether the study used the same:

ingredient identity and material;
dose and schedule;
population and health status;
duration;
measured outcome;
finished formulation and quality controls.

GOPRYME publishes the serving and ingredient information for Pure NMN 600 mg. Made in a GMP-certified facility and tested for purity. Certificates and test reports are not published on this website. We do not claim a specific purity percentage or independent third-party testing. Ingredient trials are not clinical proof for this finished product.

How should NMN benefits be communicated in Singapore?

HSA allows truthful, substantiated health-support claims but prohibits medicinal claims and statements that a supplement prevents, retards, or reverses ageing-related changes. HSA also warns against exaggerating scientific findings or using “clinically proven” as a shortcut.

A responsible page should name the population, dose, duration, measured outcome, and limitation. It should avoid translating a mechanism, animal result, or single study into a universal consumer promise.

NMN benefits questions

Does NMN increase NAD+?

Several short-term human trials have reported increased blood NAD-related measures. That result does not establish every claimed benefit or prove the identity and quality of every retail product.

Does NMN give you energy?

NMN is not a stimulant, and current evidence does not justify a guaranteed “feel more energy” claim.

Is NMN proven for anti-ageing?

NMN has produced ageing-relevant findings in animals and selected biomarker, functional, or metabolic signals in short human studies. Human evidence does not prove that NMN reverses ageing or extends lifespan, and a Singapore health supplement cannot make that promise.

How long were NMN studies?

Most published randomized trials have been short, commonly lasting weeks to a few months. That limits conclusions about long-term outcomes and safety.